Bristol Myers Squibb to Report Results for Second Quarter 2023 on July 27, 2023
Bristol Myers Squibb (NYSE: BMY) will announce Q2 2023 results on July 27, 2023. Executives will review financial results and address inquiries from investors and analysts during a conference call at 8:00 a.m. ET. A live webcast and conference call details are available on the company's investor website.
Positive
Bristol Myers Squibb (BMY) will announce Q2 2023 results on July 27, 2023, potentially impacting stock price.
06/08/2023 - 06:59 AM
NEW YORK --(BUSINESS WIRE)--
Bristol Myers Squibb (NYSE: BMY) will announce results for the second quarter of 2023 on Thursday, July 27, 2023. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 8:00 a.m. ET on the same date.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com . Investors and the public can register for the live conference call here . Those unable to register can access the live conference call by dialing in the U.S. toll free 1-866-777-2509 or international +1 412-317-5413. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.
A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes. A replay of the conference call will be available beginning at 11:30 a.m. ET on July 27 through 11:30 a.m. ET on August 10, 2023, by dialing in the U.S. toll free 1-877-344-7529 or international +1 412-317-0088, conference code: 7900147.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , YouTube , Facebook , and Instagram .
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20230607005862/en/
Media:
media@bms.com
Investors:
investor.relations@bms.com
Source: Bristol Myers Squibb
Bristol Myers Squibb will announce Q2 2023 results on July 27, 2023.
The conference call for Q2 2023 results will begin at 8:00 a.m. ET.
You can listen to the live webcast of the conference call on Bristol Myers Squibb's investor website.
If you cannot register, you can access the live conference call by dialing the U.S. toll free number 1-866-777-2509 or international number +1 412-317-5413.
Materials related to the conference call will be available on Bristol Myers Squibb's investor website prior to the start of the call.
Yes, a replay of the webcast will be available on Bristol Myers Squibb's investor website approximately three hours after the conference call concludes.
The conference call replay will be available from 11:30 a.m. ET on July 27 through 11:30 a.m. ET on August 10, 2023.
BMY Rankings
#4058 Ranked by Stock Gains
BMY Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
New York
About BMY
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
